Ontology highlight
ABSTRACT:
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Nasopharyngeal Carcinoma Cell
SUBMITTER:
Xinping Chen
LAB HEAD: XinPing Chen
PROVIDER: PXD058041 | Pride | 2025-11-27
REPOSITORIES: Pride
| Action | DRS | |||
|---|---|---|---|---|
| FE047LPIgB3_NPC_N54.raw | Raw | |||
| FE047LPIgB3_NPC_N55.raw | Raw | |||
| FE047LPIgB3_NPC_N56.raw | Raw | |||
| FE047LPIgB3_NPC_N57.raw | Raw | |||
| FE047LPIgB3_NPC_N58.raw | Raw |
Items per page: 5 1 - 5 of 487 |

Feng Min M Gong Wei W Zhu Xin X Zhu Juan J Hu Junjie J Xu Weihua W Ma Zhichao Z Fu Shengmiao S Chen Xinping X
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20250412
As the world's only commercially available paclitaxel liposome, Lipusu (Lip) has been clinically used in chemotherapy for >20 years, but the design concept of Lip remains largely unchanged since its initial development. Based on the study of Acetyl-CoA-carboxylase 1 (ACC1) in nasopharyngeal carcinoma (NPC), we proposed the concept of next-generation liposomes (NGL) utilizing lipid demand balance. In this study, we evaluated the feasibility of ACC1 and integrin α<sub>V</sub>β<sub>3</sub> as NPC t ...[more]